Arginine Prices Revives by 0.7% in October as Downstream Sectors Replenishes Inventories

Arginine Prices Revives by 0.7% in October as Downstream Sectors Replenishes Inventories

John Keats 27-Oct-2025

The global markets of L-Arginine have recorded a marginal uptrend in most of October 2025. The downstream demand from pharmaceutical and nutraceutical formulators have firmed their purchases and prompted replenishment after a subdued September. The Arginine buyers who ran down inventories in September and early October have created tightness in coverage which resulted in restocking. The stable production runs and an uninterrupted value chain have limited the scale of the rise. The plentiful feedstock (corn starch) have kept the input-cost inflation at bay and the prices increased by margins. The strategic prices from the Arginine suppliers, planned procurement for upcoming production cycles and inventory left from previous cycles have shaped a cautious market tone through the month. The combination of these factors have resulted in steady buyer activity which was sufficient to push prices upward but not enough to generate sharp spikes. ChemAnalyst after assessing the various market driving factors expects that the Arginine prices will trend slightly higher in upcoming period. The stakeholders should track feedstock markets and logistics indicators as secondary checks on upstream pressure.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Arginine

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.